New Algorithm Helps Predict Likelihood of Acute Kidney Injuries

August 12, 2020


Less than 1% of nearly 500,000 hospitalized patients required kidney replacement therapy.

Larger eGFR Declines Could Improve Effectiveness of Canagliflozin

July 23, 2020


Canagliflozin is a known treatment for kidney disease, as well as heart failure in patients with type 2 diabetes and diabetic nephropathy.

Investigators Identify Demographic Trends for Chronic Kidney Disease

July 17, 2020


There is a higher chronic kidney disease prevalence for individuals with lower educational levels.

New Report Highlights National COVID-19 Patient Characteristics

July 15, 2020


Chronic kidney disease and kidney failure represent the most common comorbidities for patients hospitalized with COVID-19 infections.

Albumin-Creatinine Ratio Better for Chronic Kidney Disease Screening

July 15, 2020


The estimated two-year four-variable kidney failure risk equation for individual risk using predicted ACR from PCR had discrimination similar to that of using observed ACR.

Initial eGFR Decline with Empagliflozin Has No Impact on Reduction in CV Death

June 13, 2020


Silvio Inzucchi, MD, discusses an EMPA-REG OUTCOME analysis assessing the impact of empagliflozin in patients who experience an initial dip in eGFR.

eGFR Could Serve as Biomarker for Increased CVD Risk in Healthy Individuals

April 10, 2020


New research is shining light on the use of eGFR as a biomarker for increased cardiovascular risk.

FDA Approves New Intravenous Triferic Formulation

March 27, 2020


The intravenous approach can be used regardless of what bicarbonate delivery method a dialysis center uses.

ACC House Call: Current SGLT-2 Inhibitor Standing

March 21, 2020


A discussion with a Brigham and Women's Hospital cardiologist on the research of the add-on cardiometabolic drug class.

Not All IBD Medications Linked to Increased Kidney Disease Risk

February 19, 2020


Azathioprine is linked to a slightly higher eGFR for patients with inflammatory bowel disease.